Pasar al contenido principal

APROXIMACION MULTIOMICA E INTEGRATIVA: DESCIFRANDO EL PAPEL DEL TEJIDO ADIPOSO PERIPROSTATICO EN LA INTERACCION FISIOPATOLOGICA ENTRE OBESIDAD Y LA GLANDULA PROSTATICA

PID2022-138185OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CORDOBA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors

  • Rosales-Barrios, Cristian
  • González-Sánchez, Zaida
  • Zuliani, Alessio
  • Jiménez-Vacas, Juan M.
  • Luque, Raul M
  • Pozo, David
  • Khiar, Noureddine
In this study, we present the first comparative analysis of active and passive drug delivery systems for docetaxel (DTX) in prostate cancer using supramolecular self-assembled micellar nanovectors. Specifically, we developed two novel micelles based on polydiacetylenic amphiphiles (PDA) for passive and active targeting. The active targeting micelles were designed with a prostate-specific membrane antigen (PSMA) ligand, ACUPA, to facilitate recognition by PSMA-positive cancer cells. These PDA-based micelles feature a well-defined structure with a hydrophobic PDA core and a surface functionalized with PEG, and for active targeting, ACUPA. Our micelles demonstrated excellent encapsulation capacity, significantly improving DTX solubility in water, a crucial factor for clinical drug use. In vitro studies confirmed the safety and cytotoxic profiles of both systems, with ACUPA-functionalized micelles showing notable internalization into PSMA-positive LNCaP cells, mediated through the PSMA-ACUPA interaction. In vivo imaging revealed preferential accumulation of ACUPA-functionalized nanomicelles in LNCaP xenograft tumors, suggesting enhanced retention via specific ACUPA-PSMA interactions and active uptake by LNCaP cells. Notably, Balb/c-Foxn1nu/nu early in vivo studies showed a marked reduction in tumor volume and tumor expression levels of proliferation, cell cycle progression, cell survival and anti-apoptotic markers with DTX-loaded micelles functionalized with ACUPA compared to those without ACUPA. Overall, our studies collect initial evidence regarding the feasibility of supramolecular self-assembly of ACUPA-PDA-based nanomicelles for PSMA-targeted drug chemotherapy delivery developments., Financial support was provided by the Spanish Ministry of Science and Innovation (Ref: PID2020-119949RB-I00 and PID2023-152689OB-I00 to NK; RTI2018-098432-B-100 to DP, PID2022-1381850B-I00 to RML), the Andalusian Ministry of Economy, Science and Innovation cofinanced by the European Regional Development Fund (ERDF) from FEDER and the European Social Fund (ESF) (PY20_00882 and CV20-04221 to NK, and postodoctoral fellowship “POSTDOC_21_00594” to AZ), the CSIC (CSIC-COV19-047 to NK), Andalusian Ministry of Health (PI-0232-2022 to ZGS and DP) and the PAIDI Program from the Andalusian Government (FQM-313 to NK). The COST action CA-18132 “Functional Glyconanomaterials for the Development of Diagnostic and Targeted Therapeutic Probe” is also acknowledged. ZGS holds a postdoctoral fellowship from the María Zambrano program (21-20073; Spanish Government, Ministry of Universities, NextGeneration EU). We also thank the Centre of Research Technology and Innovation of the University of Seville (CITIUS) for the use of TEM, HRMS and NMR facilities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets

  • Fuentes-Fayos, Antonio C.
  • García García, Miguel E.
  • Sánchez-Medianero, Teresa
  • Apps, John
  • Flores-Martínez, Álvaro
  • Rosa-Herencia, Ana S. de la
  • Gil-Duque, Ignacio
  • Otto, Georg
  • Venegas Moreno, Eva
  • Cárdenas Ruiz-Valdepeñas, Eugenio
  • Herrera-Martínez, Aura D.
  • Solivera, Juan
  • Gahete, Manuel D.
  • Cano, David A.
  • Ortega-Salas, Rosa
  • Soto-Moreno, Alfonso
  • Gálvez-Moreno, María Ángeles
  • Martínez-Barberá, Juan P.
  • Luque, Raúl M.
Craniopharyngiomas are rare benign pathologies but clinically challenging tumours because of their intimate relationship with critical brain structures, leading to severe endocrine-deficiencies/comorbidities. Therefore, identifying alternative prognostic/therapeutic tools is crucial. Although dysregulated splicing is a molecular feature that characterizes almost all tumour/cancer types, the dysregulation of the components belonging to the molecular machinery controlling the splicing-process (spliceosome) remains unknown in craniopharyngiomas. Here, we uncover a profound dysregulation in the expression of relevant spliceosome-components and splicing-factors in craniopharyngiomas versus control non-tumour tissues, identifying PRPF8 and RAVER1 as key tumour suppressor factors associated with relevant oncogenic processes. Moreover, we demonstrate that the spliceosome activity inhibition using pladienolide-B in primary patient´s derived cell-cultures might serve as a potential therapeutic tool worth to be explored in humans. Altogether, our results demonstrate a drastic and clinically relevant spliceosome-associated molecular dysregulation in craniopharyngiomas, which could serve as a potential source of novel diagnostic/prognostic biomarkers and therapeutic targets., This work was funded by Junta de Andalucía (PEER-0048–410, P20_00442, BIO-0139, 1–0034-2023, RPS24665), NIHR Great Ormond Street Hospital Biomedical Research Center, Foundation of the Spanish Society of Endocrinology and Nutrition (FSEEN), Spanish Ministry of Science, Innovation and Universities (Research-Grants: PID2022-1381850B-I00, FPU20/03954), and CIBERobn., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2

  • Pérez-Gómez, Jesús M.
  • Prats-Escribano, Antonio
  • Ortea, Ignacio
  • Guzmán-Ruiz, Rocío
  • Gahete, Manuel D.
  • Malagon, María M.
  • Luque, Raúl M.
Pérez-Gómez et al., [Background]: Prostate cancer (PCa) is a hormone-dependent tumor and one of the most prevalent cancers in men worldwide. PCa progression is influenced by its interaction with the surrounding tumor microenvironment, highlighting the role of periprostatic adipose tissue (PPAT), which modulates PCa behavior through the secretion of bioactive molecules (e.g., adipokines). However, the influence of this complex cell communication, particularly under altered metabolic conditions, remains to be fully elucidated., [Methods]: We performed multiomic/bioinformatic approaches integrating transcriptomic, proteomic, and metabolomic data from PPATs and their secretome and circulating/urinary of lipocalin-2 (LCN2) levels using a well-characterized cohort [75 PCa-patients vs. 22 control subjects with benign prostate hyperplasia (BPH)]. Different prostate cell models [normal-like (PNT2) and PCa cells (DU145/LNCaP/22Rv1/PC-3)] were used to test the role of the LCN2/SLC22A17 axis in PCa cell via multiple functional (proliferation/apoptosis/migration/invasion/colony-formation/tumorsphere assays), molecular (transcriptomic/phospho-proteomic/targeted inflammatory proteomics), and preclinical (in vivo xenograft) analyses. External validation was performed using TCGA, Grasso, and Taylor cohorts, alongside longitudinal proteomic data from patient-derived xenograft models., [Results]: A signature of significantly dysregulated adipokines was identified in PPAT of PCa vs. BPH patients. Unsupervised clustering analyses revealed two distinct molecular phenotypes (T1/T2) with unique adipokine fingerprints associated with differential obesity-related comorbidities (BMI/diabetes/dyslipidemia), being LCN2 the only adipokine showing consistent dysregulation at the transcriptomic/proteomic levels. Functional experiments demonstrated that LCN2 and its receptor SLC22A17 exert context- and transformation state-dependent effects [i.e., in vitro LCN2 and SLC22A17 overexpression promoting migration capacity in normal-like cells, while suppressing aggressive phenotypes (proliferation/invasion/stemness) in malignant models; these findings being also confirmed on in vivo xenograft models]. SLC22A17 expression was progressively lost during PCa progression and associated with significantly poorer survival across multiple independent cohorts. Mechanistically, LCN2 modulated critical oncogenic and inflammatory pathways, including NF-κB, TGF-β, JAK/STAT, and inflammasome-related signaling, and showed obesity-specific associations with arachidonic acid and complement components in the PPAT secretome., [Conclusions]: These results demonstrate a profound dysregulation of the PPAT-derived adipokine profile in PCa associated with obesity-related comorbidities, and reveal a paradoxical, stage- and context-dependent dual role of the LCN2/SLC22A17 axis as a key modulator of PPAT-PCa microenvironment interactions, with potential implications for inflammation, metabolic signaling, and tumor progression., This work was funded by MICINN (PID2022—1381850B-I00; PID2019—108403-RB-100; FPU18/06009; PREP2022—000741; FPU23/02246), Junta de Andalucía (BIO-0139), and CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain. S-MF acknowledges funding from Stichting tegen Kanker and Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme (IIG_FULL_2023_001)., Peer reviewed